A proposta da transferência das unidades Endpoint Clinical e Fortrea Patient Access agiliza ainda mais o foco estratégico da Fortrea como uma organização de pesquisa sob contrato
Read more »
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure–play contract research organization
Read more »
Recursion Announces Plans to Open New Office in London
LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Read more »
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial [...] Read more »
Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth Phase
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 06, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced [...] Read more »
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
Expect to report DREAM U.S. pivotal study efficacy and safety data by early April
Achieved record [...] Read more »
Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2023
Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2023
Les données d'efficacité et de sécurité [...] Read more »
Bitdeer Announces New 4nm Bitcoin Mining Chip SEAL01
SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world–leading technology company [...] Read more »
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Mont–Saint–Guibert, [...] Read more »
Nyxoah Participera à la 34ème Oppenheimer Annual Healthcare MedTech & Services Conference
Nyxoah Participera à la 34ème Oppenheimer Annual Healthcare MedTech & Services Conference
Read more »
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
JUPITER, Fla. and NES–ZIONA, Israel, Feb. 23, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced microbial [...] Read more »
Lantronix kündigt seine neue Cloud-Software-Plattform Percepxion™ für IoT-Geräte an
IRVINE, Kalifornien, Feb. 22, 2024 (GLOBE NEWSWIRE) — Read more »
Lantronix Lança Percepxion™, Nova Plataforma de Software em Nuvem para Dispositivos IoT
IRVINE, Califórnia, Feb. 22, 2024 (GLOBE NEWSWIRE) — A Read more »
Lantronix annonce le lancement de Percepxion™, sa nouvelle plateforme logicielle sur le cloud dédiée aux appareils compatibles avec l’IdO
IRVINE, Californie, 22 févr. 2024 (GLOBE NEWSWIRE) — Read more »
Lantronix Announces Percepxion™, Its New Cloud Software Platform for IoT Devices
IRVINE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) — Read more »